Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells

By Du Wei   Pang Changhe   Xue Yake   Zhang Qingjun   Wei Xinting  

Oncology Letters, Vol. 10, Iss. 5, 2015-11 ,pp. : 3266-3270

Spandidos Publications

Access to resources Recommend Favorite

Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells

By Thant Aye   Nawa Akihiro   Kikkawa Fumitaka   Ichigotani Yasukatu   Zhang Yangying   Sein Thet   Amin A.R.M.   Hamaguchi Michinari  

Clinical and Experimental Metastasis, Vol. 18, Iss. 5, 2000-09 ,pp. : 423-428

Springer Publishing Company

Access to resources Recommend Favorite

miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways

By                

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1571-1580

Spandidos Publications

Access to resources Recommend Favorite

Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways

By        

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 1113-1119

Spandidos Publications

Access to resources Recommend Favorite

Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 28-35

Bentham Science Publishers

Access to resources Recommend Favorite